Table 1.
Comparison of characteristics and symptoms between the hypertensive and nonhypertensive groups infected with COVID-19
| Hypertension | Normotension | P value | Hypertension | Normotension | P value | |
|---|---|---|---|---|---|---|
| Mildly ill cases (n = 155) | Mildly ill cases (n = 152) | Severely ill cases (n = 160) | Severely ill cases (n = 156) | |||
| Age (years) | 61 (56–67) | 52 (41–63) | 0.001 | 67 (61–74) | 60 (57–67) | 0.007 |
| Sex | ||||||
| Men, n (%) | 68 (43.9%) | 72 (47.4%) | 0.538 | 72 (45.0%) | 64 (41.02%) | 0.476 |
| Women, n (%) | 87 (56.1%) | 80 (52.6%) | 0.538 | 88 (55.0%) | 92 (58.98%) | 0.476 |
| Comorbidity | ||||||
| Hypertension, n (%) | 155 (100%) | 0 | — | 160 (100%) | 0 | — |
| Diabetes, n (%) | 61 (39.4%) | 43 (28.3%) | 0.041 | 56 (35%) | 33 (21.2%) | 0.006 |
| Cardiovascular disease, n (%) | 52 (34.2%) | 31 (20.4%) | 0.009 | 55 (34.4%) | 29 (18.6%) | 0.001 |
| Cerebral infarction, n (%) | 28 (18.1%) | 15 (9.9%) | 0.039 | 26 (16.25%) | 12 (7.7%) | 0.019 |
| Chronic obstructive pulmonary disease | 12 (7.7%) | 8 (5.3%) | 0.379 | 14 (8.75%) | 9 (5.8%) | 0.237 |
| malignancy, n (%) | 0 | 2 (1.3%) | — | 5 (3.1%) | 2 (1.3%) | 0.266 |
| Signs and symptoms | ||||||
| Fever, n (%) | 86 (55.5%) | 130 (85.5%) | <0.001 | 92 (57.5%) | 135 (86.5%) | <0.001 |
| Highest temperature, °C | ||||||
| <37.3 n (%) | 69 (44.5%) | 22 (14.5%) | <0.001 | 68 (42.5%) | 21 (13.5%) | <0.001 |
| 37.3–38.0 n (%) | 42 (27.1%) | 72 (47.4%) | <0.001 | 41 (26.5%) | 72 (47.4%) | <0.001 |
| 38.1–39 n (%) | 34 (29.7%) | 44 (18.9%) | 0.158 | 38 (23.8%) | 42 (26.9%) | 0.517 |
| >39 n (%) | 10 (7.1%) | 14 (13.2%) | 0.368 | 13 (8.1%) | 21 (13.5%) | 0.126 |
| Cough, n (%) | 68 (43.8%) | 52 (34.2%) | 0.083 | 51 (31.9%) | 62 (39.7%) | 0.145 |
| Fatigue, n (%) | 52 (33.5%) | 38 (25.0%) | 0.1 | 28 (17.5%) | 17 (10.9%) | 0.093 |
| Pharyngalgia, n (%) | 26 (16.8%) | 18 (11.8%) | 0.218 | 17 (10.6%) | 9 (5.8%) | 0.116 |
| Myalgia, n (%) | 13 (8.4%) | 10 (6.6%) | 0.547 | 8 (5%) | 5 (3.2%) | 0.422 |
| Sputum production, n (%) | 7 (4.5%) | 4 (2.6%) | 0.374 | 9 (5.6%) | 11 (7.1%) | 0.603 |
| Dyspnea, n (%) | 5 (3.2%) | 3 (1.9%) | 0.491 | 9 (5.6%) | 8 (5.1%) | 0.834 |
| Headache, n (%) | 8 (5.2%) | 5 (3.3%) | 0.415 | 4 (2.5%) | 3 (1.9%) | 0.728 |
| Fear of cold, n (%) | 4 (2.6%) | 2 (1.3%) | 0.423 | 6 (3.8%) | 4 (2.6%) | 0.547 |
| Anorexia, n (%) | 4 (2.6%) | 2 (1.3%) | 0.423 | 4 (2.5%) | 3 (1.9%) | 0.728 |
| Diarrhea, n (%) | 5 (3.2%) | 1 (0.6%) | 0.104 | 3 (1.9%) | 4 (2.6%) | 0.677 |
| Chest tightness, n (%) | 4 (2.6%) | 4 (2.6%) | 0.423 | 3 (1.9%) | 4 (2.6%) | 0.677 |
| Chest pain, n (%) | 2 (1.3%) | 1 (0.6%) | 0.573 | 4 (2.5%) | 3 (1.9%) | 0.728 |
| Retching, n (%) | 3 (1.9%) | 2 (1.3%) | 0.668 | 2 (1.3%) | 2 (1.3%) | 0.980 |
| Palpitation, n (%) | 4 (2.6%) | 2 (1.3%) | 0.423 | 1 (0.6%) | 1 (0.6%) | 0.986 |
| Hemoptysis, n (%) | 0 | 0 | — | 2 (1.3%) | 1 (0.6%) | 0.989 |